Shandong Weigao Group Medical Polymer Company Limited
SHWGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $13,087,071 | $13,229,453 | $13,619,007 | $13,151,719 |
| % Growth | -1.1% | -2.9% | 3.6% | – |
| Cost of Goods Sold | $6,506,440 | $6,586,420 | $6,505,925 | $5,882,315 |
| Gross Profit | $6,580,631 | $6,643,033 | $7,305,732 | $7,352,893 |
| % Margin | 50.3% | 50.2% | 53.6% | 55.9% |
| R&D Expenses | $625,233 | $592,850 | $546,552 | $492,133 |
| G&A Expenses | $1,293,603 | $1,249,983 | $1,116,689 | $1,111,777 |
| SG&A Expenses | $3,628,787 | $3,832,220 | $3,543,766 | $3,773,472 |
| Sales & Mktg Exp. | $2,335,184 | $2,582,237 | $2,536,450 | $2,695,065 |
| Other Operating Expenses | -$59,563 | -$79,142 | -$124,698 | -$113,213 |
| Operating Expenses | $4,194,457 | $4,345,928 | $3,965,620 | $4,152,392 |
| Operating Income | $2,386,174 | $2,297,105 | $2,924,464 | $2,887,600 |
| % Margin | 18.2% | 17.4% | 21.5% | 22% |
| Other Income/Exp. Net | $167,574 | $72,082 | $461,275 | -$9,755 |
| Pre-Tax Income | $2,553,748 | $2,369,187 | $3,385,739 | $2,877,845 |
| Tax Expense | $391,032 | $307,585 | $435,589 | $420,066 |
| Net Income | $2,066,668 | $2,001,906 | $2,764,093 | $2,275,929 |
| % Margin | 15.8% | 15.1% | 20.3% | 17.3% |
| EPS | 0.46 | 0.44 | 0.61 | 0.51 |
| % Growth | 4.5% | -27.9% | 19.6% | – |
| EPS Diluted | 0.45 | 0.44 | 0.61 | 0.5 |
| Weighted Avg Shares Out | 4,538,682 | 4,549,786 | 4,505,556 | 4,500,994 |
| Weighted Avg Shares Out Dil | 4,548,707 | 4,540,100 | 4,526,649 | 4,516,323 |
| Supplemental Information | – | – | – | – |
| Interest Income | $230,423 | $235,678 | $181,410 | $143,943 |
| Interest Expense | $249,572 | $272,971 | $191,401 | $140,396 |
| Depreciation & Amortization | $971,796 | $911,704 | $803,144 | $736,670 |
| EBITDA | $3,775,116 | $3,553,862 | $4,380,284 | $3,754,956 |
| % Margin | 28.8% | 26.9% | 32.2% | 28.6% |